Zacks Research Weighs in on DENTSPLY SIRONA Inc.’s Q2 2025 Earnings (NASDAQ:XRAY)

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) – Zacks Research boosted their Q2 2025 EPS estimates for shares of DENTSPLY SIRONA in a research report issued on Thursday, May 23rd. Zacks Research analyst I. Bandyopadhyay now forecasts that the medical instruments supplier will post earnings per share of $0.58 for the quarter, up from their previous estimate of $0.57. The consensus estimate for DENTSPLY SIRONA’s current full-year earnings is $2.03 per share. Zacks Research also issued estimates for DENTSPLY SIRONA’s Q3 2025 earnings at $0.60 EPS, Q1 2026 earnings at $0.60 EPS and FY2026 earnings at $2.59 EPS.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.42. The company had revenue of $953.00 million during the quarter, compared to analyst estimates of $969.45 million. DENTSPLY SIRONA had a negative net margin of 2.41% and a positive return on equity of 11.54%. The firm’s revenue for the quarter was down 2.6% on a year-over-year basis. During the same quarter last year, the business posted $0.39 EPS.

A number of other research analysts also recently issued reports on the stock. Piper Sandler reaffirmed a “neutral” rating and issued a $32.00 price objective (down previously from $35.00) on shares of DENTSPLY SIRONA in a research report on Friday, May 3rd. StockNews.com downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Friday, May 3rd. Barrington Research lowered their price objective on DENTSPLY SIRONA from $41.00 to $38.00 and set an “outperform” rating on the stock in a research report on Friday, May 3rd. The Goldman Sachs Group dropped their target price on DENTSPLY SIRONA from $34.00 to $30.00 and set a “neutral” rating on the stock in a research report on Monday, May 6th. Finally, Needham & Company LLC cut their price target on shares of DENTSPLY SIRONA from $42.00 to $36.00 and set a “buy” rating for the company in a report on Friday, May 3rd. Five equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat.com, DENTSPLY SIRONA presently has a consensus rating of “Moderate Buy” and a consensus price target of $35.22.

DENTSPLY SIRONA Trading Down 0.2 %

NASDAQ XRAY opened at $27.46 on Friday. The company’s 50-day simple moving average is $30.52 and its two-hundred day simple moving average is $32.41. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.97 and a current ratio of 1.43. DENTSPLY SIRONA has a one year low of $26.27 and a one year high of $41.65. The company has a market capitalization of $5.70 billion, a price-to-earnings ratio of -62.41, a price-to-earnings-growth ratio of 1.25 and a beta of 1.00.

DENTSPLY SIRONA Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 12th. Stockholders of record on Friday, June 28th will be issued a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 2.33%. The ex-dividend date is Friday, June 28th. DENTSPLY SIRONA’s payout ratio is -145.45%.

Institutional Trading of DENTSPLY SIRONA

Several hedge funds and other institutional investors have recently made changes to their positions in the company. VisionPoint Advisory Group LLC boosted its holdings in DENTSPLY SIRONA by 104.2% during the third quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier’s stock worth $26,000 after buying an additional 395 shares in the last quarter. Principal Securities Inc. purchased a new stake in DENTSPLY SIRONA during the fourth quarter worth about $26,000. Headlands Technologies LLC purchased a new stake in DENTSPLY SIRONA during the fourth quarter worth about $30,000. Parkside Financial Bank & Trust raised its position in DENTSPLY SIRONA by 33.3% during the fourth quarter. Parkside Financial Bank & Trust now owns 1,169 shares of the medical instruments supplier’s stock worth $42,000 after acquiring an additional 292 shares during the last quarter. Finally, Anchor Investment Management LLC acquired a new position in DENTSPLY SIRONA during the fourth quarter worth about $47,000. Hedge funds and other institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.